Skip to Main Content

Advertisement

Skip Nav Destination

Signaling pathways in breast cancer cells influence the effects of the pan erb-B kinase inhibitor CI-1033.

Cancer Res (2004) 64 (7_Supplement): 849.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal